Prostatic Pharmacokinetic/Pharmacodynamic Evaluation of Ampicillin‐Sulbactam for Bacterial Prostatitis and Preoperative Prophylaxis
Authors:
- 12 December 2020
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 61 (6) , 820-831
Abstract
This study aims to define the penetration of ampicillin and sulbactam into prostate tissue, develop a prostatic pharmacokinetic model of each drug, and assess the appropriateness of ampicillin‐sulbactam regimens for the treatment of prostatitis and the prophylaxis of postoperative infection, based on a pharmacokinetic and pharmacodynamic simulation. Subjects were prostatic hyperplasia patients prophylactically receiving a 0.5‐hour infusion of 1.5 g (1:0.5 g) or 3 g (2:1 g) ampicillin‐sulbactam before transurethral resection of the prostate. Ampicillin and sulbactam concentrations in plasma and prostate tissue were measured. The prostate tissue/plasma ratios of both ampicillin and sulbactam were approximately 0.37 (area under the drug concentration‐time curve), and penetration was similar. The prostatic population pharmacokinetic model, which included a covariate analysis, adequately predicted prostate tissue concentrations in our patient population. For therapeutic use, aiming for a bactericidal target of 50% of time above minimum inhibitory concentration (T > MIC) in prostate tissue, 3 g ampicillin‐sulbactam 4 times daily achieved ≥90% expected probability against only Enterococcus faecalis in typical patients with a creatinine clearance (CLcr) of 30 mL/min. For prophylactic use, aiming for a bacteriostatic target of 30% T > MIC, 3 g ampicillin‐sulbactam 4 times daily achieved ≥90% expected probability of attaining the bacteriostatic target against E. faecalis and Proteus species when CLcr was 30 mL/min. Based on prostatic simulations, the present study provides helpful recommendations for the treatment of bacterial prostatitis and preoperative prophylaxis in prostatectomy.Keywords
This publication has 28 references indexed in Scilit:
- Treatment of Bacterial ProstatitisClinical Infectious Diseases, 2010
- Database for Physiologically Based Pharmacokinetic (PBPK) Modeling: Physiological Data for Healthy and Health-Impaired ElderlyJournal of Toxicology and Environmental Health, Part B, 2008
- Tissue concentrations: do we ever learn?Journal of Antimicrobial Chemotherapy, 2007
- Prevention of Resistance: A Goal for Dose Selection for Antimicrobial AgentsClinical Infectious Diseases, 2003
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Penetration of ampicillin and sulbactam into human epididymis and testisInfection, 1996
- Penetration of ampicillin and sulbactam into human costal cartilageInfection, 1994
- Time-kill kinetic studies of ampicillin/sulbactam for β-Lactamase-producing enterococciDiagnostic Microbiology and Infectious Disease, 1991
- Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.Journal of Clinical Investigation, 1983
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976